Dogwood Therapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Dogwood Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $6.52 million for the year ending 2025.

  • Dogwood Therapeutics, Inc. showed a decrease of -56.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Dogwood Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Dogwood Therapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 78.1%.
  • Historical annual values: Fiscal year 2025: $6.52 million | Fiscal year 2024: $14.85 million | Fiscal year 2023: $3.32 million | Fiscal year 2022: $7.03 million | Fiscal year 2021: $14.01 million | Fiscal year 2020: $29.80 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: